镜像D-核心斯特雷普塔维丁在小鼠中表现出降低的免疫性和与天然核心斯特雷普塔维丁相比较的生物分布
Masatoshi Suganuma1, Aya Sugyo2, Hitomi Sudo2
1Central Research Laboratories, Sysmex Corporation; Healthcare Science Hub Tokyo, 1-17-8 Shinkiba, Koto-ku, Tokyo 136-0082, Japan.
Chemical & pharmaceutical bulletin
|February 18, 2026
概括
作为镜像形式的D核心链杆菌素,与小鼠的天然链杆菌素相比,其免疫性降低. 这一发现支持其在体内应用的潜力,克服了天然链杆菌素的局限性.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 自然核心链维丁的临床使用受到免疫性和生物素干扰的限制.
- 一种镜像变体的D核心链杆菌素为这些局限性提供了潜在的解决方案.
研究的目的:
- 在小鼠模型中评估D核心链杆菌素的免疫性和生物分布.
- 在免疫反应和组织分布方面,比较D核心链杆菌素与天然核心链杆菌素.
主要方法:
- 免疫性通过在小鼠内皮管内给药后的抗体产生来评估.
- 进行了蛋白酶试验,以比较D-核心和天然核心链杆菌素的降解由cathepsin B.
- 在携带瘤的小鼠中进行了生物分布研究.
主要成果:
- 自然核心链维丁诱导了抗体的产生,而D核心链维丁没有.
- 在两种形式之间观察到由cathepsin B进行的差异性蛋白质分解.
- 携带瘤的小鼠中的生物分布模式对于D核心和自然核心链杆菌素都是相似的.
结论:
- 与其天然对应物相比,D-核心链杆菌素具有显著降低的免疫性.
- 甲素B降解的差异可能解释了免疫性降低.
- D-核心链维丁是体内应用的有希望的候选物,特别是与L-生物素配对时.
相关概念视频
Immunoprecipitation
7.6K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
7.6K
Transcytosis of IgG
4.2K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.2K
Equivalence: In Vitro and In Vivo Bioequivalence
259
Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
259


